Type 1 Fibroblast Growth Factor Receptor in Cranial Neural Crest Cell-derived Mesenchyme Is Required for Palatogenesis*

Background: How Fgfr1 mutations cause cleft palate is unclear. Results: Deleting Fgfr1 in neural crest cells caused defects in both palate shelf epithelium and mesenchyme and led to cleft palate. Conclusion: FGFR1 signaling in cranial neural crest (CNC) cells regulates palate shelf growth and fusion during palatogenesis. Significance: The finding for the first time demonstrates how FGF signaling in CNC cells regulates palatogenesis. Cleft palate is a common congenital birth defect. The fibroblast growth factor (FGF) family has been shown to be important for palatogenesis, which elicits the regulatory functions by activating the FGF receptor tyrosine kinase. Mutations in Fgf or Fgfr are associated with cleft palate. To date, most mechanistic studies on FGF signaling in palate development have focused on FGFR2 in the epithelium. Although Fgfr1 is expressed in the cranial neural crest (CNC)-derived palate mesenchyme and Fgfr1 mutations are associated with palate defects, how FGFR1 in palate mesenchyme regulates palatogenesis is not well understood. Here, we reported that by using Wnt1Cre to delete Fgfr1 in neural crest cells led to cleft palate, cleft lip, and other severe craniofacial defects. Detailed analyses revealed that loss-of-function mutations in Fgfr1 did not abrogate patterning of CNC cells in palate shelves. However, it upset cell signaling in the frontofacial areas, delayed cell proliferation in both epithelial and mesenchymal compartments, prevented palate shelf elevation, and compromised palate shelf fusion. This is the first report revealing how FGF signaling in CNC cells regulates palatogenesis.

Cleft palate is a common congenital birth defect. The fibroblast growth factor (FGF) family has been shown to be important for palatogenesis, which elicits the regulatory functions by activating the FGF receptor tyrosine kinase. Mutations in Fgf or Fgfr are associated with cleft palate. To date, most mechanistic studies on FGF signaling in palate development have focused on FGFR2 in the epithelium. Although Fgfr1 is expressed in the cranial neural crest (CNC)-derived palate mesenchyme and Fgfr1 mutations are associated with palate defects, how FGFR1 in palate mesenchyme regulates palatogenesis is not well understood. Here, we reported that by using Wnt1 Cre to delete Fgfr1 in neural crest cells led to cleft palate, cleft lip, and other severe craniofacial defects. Detailed analyses revealed that loss-offunction mutations in Fgfr1 did not abrogate patterning of CNC cells in palate shelves. However, it upset cell signaling in the frontofacial areas, delayed cell proliferation in both epithelial and mesenchymal compartments, prevented palate shelf elevation, and compromised palate shelf fusion. This is the first report revealing how FGF signaling in CNC cells regulates palatogenesis.
Cleft palate is the most common congenital craniofacial defect in human, which is often associated with cleft lip. It affects about 0.1% newborns in America according to the Center for Diseases Control and Prevention. The palate is formed by fusion of the primary and secondary palates. It consists of two structural parts, the anterior bony hard palate and the posterior muscular soft palate. The primary palate is derived from the posterior protrusion of the medial nasal process, and the secondary palate develops from bilateral outgrowth of the maxillary process (1,2). Palate development is a multistep process that involves bilateral palatal shelf growth beside the tongue, elevation of the palatal shelves that grow toward the midline, fusion of palatal shelves at the midline to form the medial edge epithelium (MEE), 5 degeneration of the MEE, and disappearance of the midline epithelial seam (1,3). The maxillary shelves are mainly composed of the cranial neural crest (CNC)-derived ecto-mesenchymal cells surrounded by a thin layer of pharyngeal ectoderm-derived epithelial cells (4 -7). The CNC cells are a subset of neural crest cells (NCCs) that are pluripotent and are derived from the lateral ridges of the neural plate during early stages of embryogenesis. During craniofacial development, CNC cells migrate ventrolaterally and populate in the branchial arches, which then contribute extensively to the formation of head and neck mesenchymal structures, including the palate. Defects either in facial mesenchyme patterning and growth or in epithelium fusion result in cleft palate. Several reciprocal epithelial-mesenchymal signaling axes, including the fibroblast growth factor (FGF), bone morphogenetic protein (BMP), Sonic hedgehog (SHH), and Wnt signaling pathways, have been show to play important roles in the migration and proliferation of CNC cells (1, 8 -10).
The FGF family consists of 18 tyrosine kinase receptor-mediated members that regulate a broad spectrum of cellular activities (11). FGF elicits its regulatory signals via binding and activating the FGF receptor (FGFR) tyrosine kinases encoded by four highly homologous genes. In the palate, FGF and FGFR isoforms are expressed in a spatiotemporally specific manner and constitute a directional regulatory axis between the stromal and epithelial compartments, regulating palate development (12). In palate shelves, Fgf10 expression is restricted to the mesenchyme and Fgfr2b expression to the overlying epithelium. Germ line ablation of Fgf10 or epithelium-specific deletion of Fgfr2b leads to cleft palate with impaired palatal shelf outgrowth (13,14). Cell proliferation in both epithelium and mesenchyme compartments is reduced in the absence of either Fgf10 or Fgfr2b, suggesting that ablation of the FGF10-FGFR2 signaling axis causes loss of signals from the epithelium back to the underlying mesenchyme, which regulate mesenchymal proliferation. In addition, the FGF signaling intensity during palatogenesis is delicately balanced. Expression of a constitutively active FGFR2 mutant in the epithelium increases palatal shelf mesenchyme proliferation and delays elevation of the shelves, resulting in cleft palate and other craniofacial disorders (15,16). Disruption of Sprouty 2 (Spry2), a negative feedback regulator of FGF signaling pathways, results in abnormal palate formation (17). In contrast, ablation of Fgfr1 in the epithelium with K14 promoter driven Cre does not cause major craniofacial defects (18). The major cell population in the palate shelf mesenchyme is derived from CNC cells, which expresses Fgfr1 (19). Although it has been reported that embryos with Fgfr1 ablation in NCCs have cleft palate (20), no detailed characterization has been done on how ablation of Fgfr1 in NCCs leads to cleft palate. As FGFR1 is important for patterning in the pharyngeal region (20), its mutations and haploinsufficiency in humans are associated with cleft palate (21)(22)(23).
To investigate how mesenchymal FGFR1 regulates craniofacial development, Fgfr1 alleles were tissue-specifically ablated in NCCs by crossing mice bearing floxed Fgfr1 (Fgfr1 flox ) and Wnt1-Cre (Wnt1 Cre ) transgenic alleles. Ablation of Fgfr1 in NCCs led to cleft palate, cleft lip, and other severe craniofacial defects. Detailed characterization revealed that ablation of Fgfr1 in NCCs did not abrogate CNC cell contribution to the palate shelf mesenchyme. However, it upset cell signaling in the medial nasal process and maxillary process areas, and it delayed cell proliferation in both the mesenchyme and epithelium of palatal shelves. The mutant palate shelves failed to elevate during palatogenesis. In addition, although it did not fully prevent the fusion process, it compromised the deterioration of the MEE. Together with the report that loss of the mesenchymalepithelial FGF10-FGFR2IIIb signaling axis affects cell proliferation in both epithelium and mesenchyme (13), the results indicate that the reciprocal FGF signaling axis between the palate mesenchyme and epithelium is important for the growth and elevation of palate shelves. This is the first report on the mechanism by which mesenchymal FGFR1 signaling regulates palatogenesis.

MATERIALS AND METHODS
Animals and Isolation of Tissues-All animals were housed at the Program of Animal Resources, Institute of Biosciences and Technology, Texas A&M Health Science Center, and were handled in accordance with the principles and procedures in the Guide for the Care and Use of Laboratory Animals. All experi-mental procedures were approved by the Institutional Animal Care and Use Committee. Mice carrying the Wnt1 Cre transgenic alleles (24), ROSA26 lacZ (25) reporter allele, and Fgfr1 flox allele (26) were maintained and genotyped as described previously.
Dissection and in Vitro Culture of Palate Shelves-Palatal shelves were dissected from E13.5 embryos. Two palatal shelves were placed on 8-m-pore size transwell culture plates (BD Biosciences) with their MEE placed in close apposition without apparent distortion of their tissue shape. The paired palate shelves were cultured for 2 days at 37°C in DMEM supplemented with 1% penicillin/streptomycin (27). Similar ex vivo cultures were carried with heads without the tongue and mandible from E13.5 embryos (28).
Histological and Immunohistochemical Analyses-Prenatal mouse heads were fixed in 4% paraformaldehyde solution for 2 h at 4°C. The fixed tissues were serially dehydrated with ethanol, embedded in paraffin, and sectioned at 5-m thickness according to standard procedures. Immunohistochemical analyses were performed on paraffin sections mounted on Superfrost/Plus slides (Fisher). Antigens were retrieved by boiling in citrate buffer (10 mM) for 20 min at 100°C or as suggested by the manufacturers. All sections were incubated with primary antibodies diluted in PBS at 4°C overnight. The mouse anti-p63 (1:200) and mouse anti-pan-cytokeratin (1:200) antibodies were purchased from Santa Cruz Biotechnology, and rabbit anti-E-cadherin (1:200), rabbit anti-pSmad1/5/8 (1:200), and rabbit anti-vimentin (1:200) antibodies were purchased from Cell Signaling Technology. Specifically bound antibodies were detected with FITC-conjugated secondary antibodies (Invitrogen) and visualized with a Zeiss LSM 510 confocal microscope. To-Pro3 was used for nuclear counterstaining.
For LacZ staining, the tissues were first lightly fixed with 0.2% glutaraldehyde for 30 min and then incubated overnight with 1 mg/ml X-Gal at room temperature. The tissues were post-fixed with 4% paraformaldehyde at room temperature for 1 h after a 10-min PBS wash. The tissues were then dehydrated, paraffinembedded, and sectioned according to regular procedures.
Gene Expression Analysis-Total RNA was extracted with the RiboPure RNA isolation reagent (Ambion, TX). Reverse transcription was carried out with SuperScript III (Invitrogen) and random primers. Real time PCR was performed on Mx3000 (Stratagene), using the SYBR Green JumpStart Taq ReadyMix (Sigma) with pairs of primers specific for each transcript and following the manufacturer's protocol. The ratio between expression levels in the two samples was calculated by relative quantification, using ␤-actin as a reference transcript for normalization. The primer sequences are listed in Table 1.
For in situ hybridization, paraffin-embedded tissue sections were rehydrated followed by digestion with 20 g/ml protease K for 7 min at room temperature. After prehybridization at 65°C for 2 h, the hybridization was carried out by overnight incubation at 65°C with 0.5 g/ml digoxigenin-labeled RNA probes for the indicated genes. Nonspecifically bound probes were removed by washing four times with 0.1ϫ digoxigenin washing buffer at 60°C for 30 min. Specifically bound probes were later detected using alkaline phosphatase-conjugated anti-digoxigenin antibody (Roche Applied Science).
The antisense riboprobe of FGFR1 was generated by in vitro transcription using T3 RNA polymerase with the XbaI-linearized pKSϩ⌬FGFR1 vector (generous gift from Dr. Juha Partanen) (26). The antisense riboprobe of TGF␤3 was generated by in vitro transcription using T3 RNA polymerase with the EcoRI-linearized pSK-TGF␤3 vector (kindly provided by Dr. Rulang Jiang) (29).

Ablation of Fgfr1 in NCCs Causes Cleft Palate-Mutations in
Fgfr1 have been found to be associated with craniofacial malformation, including cleft palate in human. Fgfr1 is expressed in CNC-derived mesenchymal cells during palatogenesis (19). To investigate how FGFR1 signaling in CNC cells affected craniofacial development, the Fgfr1 alleles were tissue-specifically ablated in NCCs by crossing the mice bearing Fgfr1 flox and Wnt1 Cre alleles. Although they appeared to be morphologically normal at E10.5, Fgfr1 conditional knock-out (Fgfr1 cKO ) mutant embryos had a slightly reduced frontonasal prominence and maxillary processes (Fig. 1A). LacZ staining of the Fgfr1 cKO and wild type embryos bearing the ROSA26 lacZ reporter demonstrated that, compared with the Fgfr1 wild type control at this stage, the CNC cell participation in the frontonasal prominence was significantly reduced in mutant embryos (Fig. 1B), which was in line with the report that FGFR1 is required for CNC cell patterning (20). In contrast, LacZ staining of coronal sections of E10.5 embryos showed no difference in ROSA26 lacZ reporter activation between wild type and mutant embryos (Fig. 1B,  insets), indicating neural tube formation was not affected in mutant embryos.
The structures constituted by fused midline nasal prominence were missing in mutant embryos at the E14.5 and neonatal stage (Fig. 1C). Completely cleft primary and secondary palates as well as cleft lip were readily seen. Partially formed palate rugae were observed in mutant mice at the neonatal stage. The palatal shelves were widely separated in mutant mice, allowing direct view of the underlying presphenoid bone. In addition, the mutant embryos also exhibited other severe orofacial dysformation, including tooth bud defect and micrognathia. Embryos bearing one conditional null Fgfr1 allele, one or two Fgfr1 flox alleles without the Cre allele, or one Cre allele were indistinguishable from wild type embryos, and hereafter were defined as controls.
Ablation of Fgfr1 in NCCs Does Not Disrupt Participation of CNC Cells in Palate Shelves-To characterize the palate defects in Fgfr1 cKO embryos, coronal sections of E13.5, E14.5, and E15.5 embryos were H&E-stained for histological analyses. At the stage of E14.5, the anterior portion of the secondary palate in Fgfr1 flox embryos was undergoing fusing process, and the MEE was formed, whereas the posterior portion had finished the elevation but was still undergoing expansion processes. The mutant palate shelves, however, were still growing downward at both anterior and posterior positions (Fig. 2, A and B). The palate shelves failed to elevate and finish the fusion processes even at E15.5 stages. Although mesoderm-derived mesenchymal cells also contribute to palate shelves as a minor cell population, the majority of palate shelf mesenchymal cells were derived from the CNC (30,31). Lineage tracing with the  ROSA26 lacZ reporter allele revealed that similar to the Fgfr1 flox palate shelves, the majority of mesenchymal cells in mutant palate shelves were derived from Wnt1 Cre -expressing CNC cells (Fig. 3, A and B). However, there were a fraction of cells adjacent to the epithelial cells that were not X-Gal-labeled. The origin of these cells remains to be determined. In situ hybridization revealed that Fgfr1 expression in the palate shelf mesenchyme was diminished (Fig. 3C). In addition, all cells in the mutant palate shelf mesenchyme were vimentin-positive (Fig.  3D), indicating mesenchymal cells. The size of mutant palate shelves appeared to be smaller than the control at E13.5 (Fig. 2). To determine whether cell proliferation was a causal factor for small palate shelves, BrdU incorporation assays were employed to assess the proliferating cell numbers in palate shelves at the stages of E12.5 to E14.5 (Fig. 4). The results showed that cell proliferation in the epithelium of anterior palate shelves and the mesenchyme at the posterior shelves were reduced at E12.5-13.5, although no differences were found in the anterior mesenchyme and the posterior epithelium in palate shelves (Fig. 4, A and B). However, both the epithelium and mesenchyme of anterior and the mesenchyme of posterior Fgfr1 cKO palate shelves had a higher proliferation than control at E14.5, although the posterior epithelium of Fgfr1 cKO palate shelves had a similar proliferation activity as the control (Fig. 4C). Thus, it appeared that the cell proliferation in Fgfr1 cKO palate shelves was delayed, rather than simply reduced. The data suggest that lack of FGFR1 signals in CNC-derived mesenchymal cells in palate shelves results in reduced epithelium proliferation at a noncell autonomous manner.

Lacking FGFR1 Signals in CNC-derived Mesenchymal Cells
Affects Degeneration of MEE in Palate Shelves-During the fusion process of palate shelves, cells in the MEE undergo degeneration and the midline epithelial seam disappears at the end. Fgfr1 cKO embryos exhibited multiple craniofacial defects, including micrognathia and heightened tongue, which had been shown to provide a steric hindrance for palate shelf elevation without the fusion process (32)(33)(34)(35)(36)(37)(38)(39). To determine whether lacking mesenchymal FGFR1 affected the fusion directly by compromising epithelial degeneration or indirectly by providing a steric hindrance, E13.5 embryonic heads without the tongue and mandibles were dissected for ex vivo cultures for 48 h. Although the palate shelves of both control and Fgfr1 cKO embryos did not complete the fusion process, the gap between the two shelves was significantly reduced (Fig. 5A). However, when the two palate shelves were dissected and placed in a proximal apposition, the fusion took place in both control and mutant palate shelves in 2 days (Fig. 5B). H&E staining of the ex vivo cultured E13.5 palate shelves showed that both control and Fgfr1 cKO palate shelves fused after being cultured for 2 days. However, the gap between the two mutant shelves was not fully filled by mesenchymal cells as the control. In addition, there was still a fraction of midline epithelial seam remained (Fig. 5C). Immunostaining further revealed that expression of epithelial characteristic cytokeratins in the mutant MEE was not eliminated as completely as in controls (Fig. 5D). The results indicate that although it did not abolish the process, ablation of Fgfr1 in CNC-derived mesenchymal cells compromised the deterioration of MEE cells during the fusion. p63 is expressed in palate epithelial cells and is often used as an indicator for palate epithelial cell integrity. Immunostaining showed that the MEEs in control palate shelves had a fuzzy E-cadherin staining, which was a sign of deteriorating epithelial cells. The MEE cells in mutant anterior palate shelves also were not intact even though they did not undergo elevation and fusion processes. However, the severity of degeneration was apparently compromised (Fig. 6A). Similarly, E-cadherin staining also showed that, compared with the control, Fgfr1 cKO palate shelves had less defused E-cadherin staining in MEE cells at this stage (Fig. 6B). In addition, TUNEL analyses showed that although MEE cells in mutant palate shelves still had apoptotic cells, the numbers were significantly lower than those in control palate shelves (Fig. 6C). Consistently, expression of Tgf␤3 in MEE cells was reduced in Fgfr1 cKO embryos (Fig. 6D), which plays a critical role in promoting fusion of the palatal shelves (40). Together, the results showed that these characteristic changes in MEE were apparently less obvious in E14.5 Fgfr1 cKO embryos than those in the control. Therefore, although not essential, FGFR1 signaling in CNC-derived mesenchymal cells  is involved in regulating degeneration of the MEE during palate shelf fusion through non-cell autonomous mechanisms. However, the molecular mechanism by which FGFR1 signaling in CNC-derived mesenchymal cells affects MEE cell degeneration and proliferation remains to be characterized.
Ablation of Fgfr1 in NCCs Affects Cell Signaling in Frontofacial Tissues-To further characterize how ablation of Fgfr1 in CNC cells affected cell signaling during craniofacial development, real time RT-PCR analyses were carried out to assess expression of key regulatory molecules in craniofacial development at E10.5 embryos and E14.5 frontofacial tissues. The results clearly demonstrated that expression of Notch1 and Bmp4 was increased, and the expression of Wnt1 was reduced in the E10.5 Fgfr1 cKO embryos (Fig. 7A). To better assess the FGFR1-regulated gene expression in frontofacial development, the frontofacial part of E14.5 embryos was dissected for real time RT-PCR analyses. The results confirmed that both Wnt and BMP signalings were changed by NCC-specific deletion of Fgfr1 in E14.5 frontofacial tissues (Fig. 7B). In addition, expression of Msx1 and Ptx1 was also reduced in mutant frontofacial tissues. Furthermore, immunostaining showed that phosphorylated Smad1/5/8-positive cells were significantly increased in Fgfr1 cKO palate shelves, especially in the anterior part at E14.5 stage (Fig. 7C). This further demonstrated increased BMP signaling in Fgfr1 cKO palate shelves.

DISCUSSION
The FGF signaling axis is critical for palate development through directional and reciprocal communications between the mesenchyme and epithelium of palate shelves. To date, the majority of studies has been focused on the FGF7/10-FGFR2 signaling axis that directionally mediates the mesenchyme to epithelium communication. How FGF signaling, especially that mediated by FGFR1, in the CNC cells regulates palate formation is not understood. Here, we report that tissue-specific ablation of Fgfr1 in NCCs with Wnt1 Cre caused primary and secondary cleft palate, cleft lip, and other craniofacial detects. Detailed analyses revealed that ablation of Fgfr1 in NCCs did not abrogate patterning of CNC-derived mesenchymal cells in the palate shelves. However, it delayed cell proliferation in both the mesenchyme and epithelium, and impeded development of medial nasal processes and the lift of palate shelves during palatogenesis. In addition, although it did not fully prevent the fusion process of ex vivo cultured palate shelves once they were placed in a close contact position, the deterioration of the MEE in mutant palatal shelves was compromised. The detailed mechanism regarding how ablation of Fgfr1 in the mesenchyme affects cell proliferation in Fgfr1-intact epithelial cells remains to be determined, although quantitative RT-PCR analyses showed altered expression of Bmp, Wnt, and other signaling molecules in the frontofacial tissue of E14.5 Fgfr1 mutant  embryos. In addition, ablation of Fgfr1 in NCCs affected BMP and Wnt signaling in E10.5 embryos. This further demonstrates the cross-talk between FGF and other signaling pathways during embryonic development.
Palate development is a multifactorial event and is regulated by multiple signaling pathways. The cross-talk of these intertwining pathways is important in regulating palatogenesis (1), and the FGF signaling pathway is no exception. Balance in FGF signaling appears to be important for palate formation. Constitutively activating mutations in FGFR1 and FGFR2 as well as loss of function mutation of FGFR1 lead to cleft palate. Suppression of FGFR signaling via FGFR kinase inhibitor causes palate defects (41). Many sporadic mutations of FGFR1 and FGFR2, as well as FGF3, FGF7, FGF8, FGF10, and FGF18, cause palate malformations in human. These include Kallmann, Pfeiffer, Apert, and Crouzon syndromes where cleft palate is part of a broad craniofacial phenotype (22,42,43). In addition, FGFR1 is widely expressed in the myofibroblasts of injured palate, suggesting that FGFR1 signaling is also important for palate repair during injury (44). Sprys are decoys for FGFR substrates functioning as negative regulators of FGFR signaling, which are expressed in the FGF signaling domains during mouse craniofacial development (45). On the one hand, deletion of Spry2 intensifies FGF signaling intensity, which leads to increased cellular proliferation in the palate shelves and cleft palate (46), without affecting palate shelf fusion in the in vitro organ culture system (17). On the other hand, insufficient FGFR1 signaling due to loss-of-function mutations or haploid insufficiency of Fgfr1 also leads to defects in palatogenesis. However, how FGFR1 regulates palatogenesis has not been completely clear. Interestingly, our data here showed that although ablation of Fgfr1 in NCCs did not prevent patterning of CNC cells in palate shelves, it affected cell proliferation and abrogated palate shelf elevation. It did not fully disrupt palate shelf fusion once they were adjacent. Together with the literature, these results suggest that a precise balance of FGFR1 signaling is required for CNC-derived mesenchymal cell proliferation and change in palate shelf conformation. Both excess and deficiency of FGFR1 signaling led to defects in palatogenesis.
As a key step in palatogenesis, the palate shelves changed their conformation and elevated prior to the fusion stage. Ablation of Fgfr1 in NCCs led to failure in changing palate shelf conformation during palatogenesis (Fig. 2). To date, the mechanism underlying conformational change of palate shelves is not well understood. Several mechanisms have been proposed, which include alteration in cellular proliferation, apoptosis, cell adhesion, or glycosaminoglycan (GAG) content in the extracellular matrix (3). Our data showed that mesenchymal proliferation was decreased at first and then increased in Fgfr1 mutant palate shelves, indicating that proliferation was delayed but not disrupted. Therefore, failure of changing palate shelf conformation in Fgfr1 mutants is not likely due to compromised cell proliferation in the palate shelves. Emerging data show that the composition of GAG in the extracellular matrix varies in different cell types and that the GAG also participates in cell signaling (11). FGF2 has been shown to modulate GAG expression and stimulate hyaluronan synthase genes in vitro (47). Embryos bearing the Fgfr2C342Y mutant show delayed palate elevation and reduced levels of mesenchymal GAGs. Reduced levels of feedback regulators of FGF signaling suggest that this gain-offunction mutation in FGFR2 ultimately resembles loss of FGF function in the palate mesenchyme (15). Future work to characterize GAG compositions in Fgfr1 cKO palate shelves is needed to assess the possibility that loss of Fgfr1 in CNC-derived mesenchymal cells changes GAG compositions and impairs palate shelf elevation required for palate shelf fusion.
In vitro experiments with control and Fgfr1 mutant palate shelves showed that although mutant palate shelves also fused and formed the MEE when they were placed in a proximal position, the degeneration of MEE cells was compromised (Fig. 5). This indicates that although not essential, FGFR1 signals in CNC-derived mesenchymal cells play an important role in controlling MEE degeneration during palate fusion. The results are different from previous findings that palatal fusion is not affected by the Crouzon gain-of-function FGFR mutation or Spry2 deficiency (15,17,45). Interestingly, it has been shown that FGF18 from the mesenchyme induces Runx1 that is expressed in the epithelium, which regulates epithelial-mesenchymal transition and morphological changes in the MEE cells during palate fusion (48).
The expression patterns and roles of Msx1, Bmp2, and Bmp4 in palate formation have been extensively studied (49,50). Msx1 is expressed in palatal mesenchyme and is required for expression of Bmp4 in the mesenchyme but not the epithelium. The expression of Bmp2 can also be indirectly regulated by Msx1 (49). Msx1-BMP signaling is required for the proliferation of palatal mesenchyme as well as apoptosis of palatal epithelium, (8,49). Gain-of-function of BMP signaling due to loss of Noggin leads to deregulated cell proliferation, cell death, and changes in gene expression in palate shelves (50). Wnt signaling also plays critical roles in palate formation (51). Enhanced cell apoptosis in the palatal epithelium and deregulation of cell proliferation in palatal shelves are associated with increased Bmp signaling intensity (50). In line with these reports, our RT-PCR analyses showed that ablation of Fgfr1 in CNC cells led to aberrant expression of Msx1, Bmp2, Bmp4, and Wnt signaling components in Fgfr1 cKO E10.5 embryos and frontofacial tissues of E14.5 embryos (Fig. 7). However, whether changes in expression of the Msx1-Bmp axis during E10.5-E14.5 are causal factors of deregulated cell proliferation and apoptosis in Fgfr1 cKO palatal shelves remains unanswered. Further ex vivo or in vivo studies are needed to reveal the molecular mechanism by which mesenchymal FGFR1 signals regulate expression of these signaling molecules during palate formation.
In summary, ablation of Fgfr1 in the NCCs delayed cell proliferation in both mesenchymal and epithelial compartments of palate shelves and abrogated palate shelf elevation; it did not fully disrupt the palate shelf fusion but compromised deterioration of the MEE during the process. This is the first report demonstrating the mechanism by which the FGFR1 signaling in CNC cells regulates palatogenesis.